Insights on how the Mycobacterium tuberculosis heme uptake pathway can be used as a drug target

Future Medicinal Chemistry

Volumn 5, Issue 12, 2013, Pages 1391-1403

  Owens, Cedric P ^a,b   Chim, Nicholas ^a   Goulding, Celia W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEDAQUILINE; BINDING PROTEIN; HEME; HEMOPROTEIN; MEMBRANE PROTEIN; METAL ION; MMPL11 PROTEIN; MMPL3 PROTEIN; N (2 ADAMANTYL) N' GERANYLETHYLENEDIAMINE; RV0203 PROTEIN; SIDEROPHORE; SUTEZOLID; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACILLUS ANTHRACIS; BINDING SITE; CRYSTAL STRUCTURE; CYTOSOL; CYTOTOXICITY; DRUG DELIVERY SYSTEM; GROWTH INHIBITION; IRON TRANSPORT; MOLECULAR EVOLUTION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA ENTERICA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS;

EID: 84881498792     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.13.109     Document Type: Review

References (98)

1. Lyons TJ, Eide DJ. Transport and Storage of Metal Ions in Biology. In: Bioinorganic Chemistry. Bertini I, Gray HB, Lippard SJ, Valentine JS (Eds). University Science Books, Mill Valley, CA, USA (1994).
2. Aisen P. Chemistry and biology of eukaryotic iron metabolism. Int. J. Biochem. Cell Biol. 33(10), 940-959 (2001).
3. Hider RC, Kong X. Chemistry and biology of siderophores. Nat. Prod. Rep. 27(5), 637 (2010).
4. Ratledge C. Iron, mycobacteria and tuberculosis. Tuberculosis (Edinb). 84(1-2), 110-130 (2004).
5. Sandy M, Butler A. Microbial iron acquisition: marine and terrestrial siderophores. Chem. Rev. 109(10), 4580-4595 (2009).
6. Hoette TM, Clifton MC, Zawadzka AM, Holmes MA, Strong RK, Raymond KN. Immune interference in Mycobacterium tuberculosis intracellular iron acquisition through siderocalin recognition of carboxymycobactins. ACS Chem. Biol. 6(12), 1327-1331 (2011).
7. Johnson EE, Srikanth CV, Sandgren A et al. Siderocalin inhibits the intracellular replication of Mycobacterium tuberculosis in macrophages. FEMS Immunol. Med. Microbiol. 58(1), 138-145 (2010).
8. Müller SI, Valdebenito M, Hantke K. Salmochelin, the long-overlooked catecholate siderophore of Salmonella. Biometals 22(4), 691-695 (2009).
9. Cornelissen CN. Transferrin-iron uptake by Gram-negative bacteria. Front. Biosci. 8, d836-d847 (2003).
10. Beddek AJ, Schryvers AB. The lactoferrin receptor complex in Gram negative bacteria. Biometals 23(3), 377-386 (2010).
11. Dehner C, Morales-Soto N, Behera RK et al. Ferritin and ferrihydrite nanoparticles as iron sources for Pseudomonas aeruginosa. J. Biol. Inorg. Chem. 18(3), 371-381 (2013).
12. Wandersman C, Delepelaire P. Bacterial iron sources: from siderophores to hemophores. Annu Rev Microbiol. 58, 611-647 (2004).
13. Honsa ES, Maresso AW. Mechanisms of iron import in anthrax. Biometals 24(3), 533-545 (2011).
14. Skaar EP, Humayun M, Bae T, DeBord KL, Schneewind O. Iron-source preference of Staphylococcus aureus infections. Science 305(5690), 1626-1628 (2004).
15. Mazmanian SK, Skaar EP, Gaspar AH et al. Passage of heme-iron across the envelope of Staphylococcus aureus. Science 299(5608), 906-909 (2003).
16. Tullius MV, Harmston CA, Owens CP et al. Discovery and characterization of a unique mycobacterial heme acquisition system. Proc. Natl. Acad. Sci. USA 108(12), 5051-5056 (2011).
17. Maresso AW, Garufi G, Schneewind O. Bacillus anthracis secretes proteins that mediate heme acquisition from hemoglobin. PLoS Pathog. 4(8), e1000132 (2008).
18. Izadi N, Henry Y, Haladjian J et al. Purification and characterization of an extracellular heme-binding protein, HasA, involved in heme iron acquisition. Biochemistry 36(23), 7050-7057 (1997).
19. Ochsner UA, Johnson Z, Vasil ML. Genetics and regulation of two distinct haem-uptake systems, phu and has, in Pseudomonas aeruginosa. Microbiology 146(Pt 1), 185-198 (2000).
20. Lewis JP, Dawson JA, Hannis JC, Muddiman D, Macrina FL. Hemoglobinase activity of the lysine gingipain protease (Kgp) of Porphyromonas gingivalis W83. J. Bacteriol. 181(16), 4905-4913 (1999).
21. Cescau S, Cwerman H, Létoffé S, Delepelaire P, Wandersman C, Biville F. Heme acquisition by hemophores. Biometals. 20(3-4), 603-613 (2007).
22. Wandersman C, Delepelaire P. Haemophore functions revisited. Mol. Microbiol. 85(4), 618-631 (2012).
23. Zhu H, Xie G, Liu M et al. Pathway for heme uptake from human methemoglobin by the iron-regulated surface determinants system of Staphylococcus aureus. J. Biol. Chem. 283(26), 18450-18460 (2008).
24. Grigg JC, Ukpabi G, Gaudin CFM, Murphy MEP. Structural biology of heme binding in the Staphylococcus aureus Isd system. J. Inorg. Biochem. 104(3), 341-348 (2010).
25. Yongqing T, Potempa J, Pike RN, Wijeyewickrema LC. The lysine-specific gingipain of Porphyromonas gingivalis: importance to pathogenicity and potential strategies for inhibition. Adv. Exp. Med. Biol. 712, 15-29 (2011).
26. Deniau C, Gilli R, Izadi-Pruneyre N et al. Thermodynamics of heme binding to the HasASM hemophore: effect of mutations at three key residues for heme uptake. Biochemistry 42(36), 10627-10633 (2003).
27. Bunn HF, Jandl JH. Exchange of heme among hemoglobins and between hemoglobin and albumin. J. Biol. Chem. 243(3), 465-475 (1968).
28. Hargrove MS, Singleton EW, Quillin ML et al. His64 (E7)→Tyr apomyoglobin as a reagent for measuring rates of hemin dissociation. J. Biol. Chem. 269, 4207-4214 (1994).
29. Hargrove MS. Quaternary structure regulates hemin dissociation from human hemoglobin. J. Biol. Chem. 272(28), 17385-17389 (1997).
30. Yukl ET, Jepkorir G, Alontaga AY et al. Kinetic and spectroscopic studies of hemin acquisition in the hemophore HasAp from Pseudomonas aeruginosa. Biochemistry 49(31), 6646-6654 (2010).
31. Alontaga AY, Rodriguez JC, Schönbrunn E et al. Structural characterization of the hemophore HasAp from Pseudomonas aeruginosa: NMR spectroscopy reveals protein-protein interactions between Holo-HasAp and hemoglobin. Biochemistry 48(1), 96-109 (2009).
32. Tong Y, Guo M. Bacterial heme-transport proteins and their heme-coordination modes. Arch. Biochem. Biophy. 481(1), 1-15 (2009).
33. Simpson W, Olczak T, Genco CA. Characterization and expression of HmuR, a TonB-dependent hemoglobin receptor of Porphyromonas gingivalis. J. Bacteriol. 182(20), 5737-5748 (2000).
34. Liu X, Olczak T, Guo HC, Dixon DW, Genco CA. Identification of amino acid residues involved in heme binding and hemoprotein utilization in the Porphyromonas gingivalis heme receptor HmuR. Infect. Immun. 74(2), 1222-1232 (2006).
35. Burkhard KA, Wilks A. Characterization of the outer membrane receptor ShuA from the heme uptake system of Shigella dysenteriae. Substrate specificity and identification of the heme protein ligands. J. Biol. Chem. 282(20), 15126-15136 (2007).
36. Muryoi N, Tiedemann MT, Pluym M, Cheung J, Heinrichs DE, Stillman MJ. Demonstration of the iron-regulated surface determinant (Isd) heme transfer pathway in Staphylococcus aureus. J. Biol. Chem. 283(42), 28125-28136 (2008).
37. Sroka A, Sztukowska M, Potempa J, Travis J, Genco CA. degradation of host heme proteins by lysine-and arginine-specific cysteine proteinases (Gingipains) of Porphyromonas gingivalis. J. Bacteriol. 183(19), 5609-5616 (2001).
38. Luo M, Fadeev EA, Groves JT. Mycobactin-mediated iron acquisition within macrophages. Nat. Chem. Biol. 1(3), 149-153 (2005).
39. Soe-Lin S, Apte SS, Andriopoulos B et al. Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo. Proc. Natl. Acad. Sci. USA 106(14), 5960-5965 (2009).
40. Wren BW, Stabler RA, Das SS et al. Characterization of a haemolysin from Mycobacterium tuberculosis with homology to a virulence factor of Serpulina hyodysenteriae. Microbiology (Reading, Engl.). 144(5), 1205-1211 (1998).
41. Rodriguez GM, Smith I. Identification of an ABC transporter required for iron acquisition and virulence in Mycobacterium tuberculosis. J. Bacteriol. 188(2), 424-430 (2006).
42. Ryndak MB, Wang S, Smith I, Rodriguez GM. The Mycobacterium tuberculosis high-affinity iron importer, IrtA, contains an FAD-binding domain. J. Bacteriol. 192(3), 861-869 (2010).
43. Siegrist MS, Unnikrishnan M, McConnell MJ et al. Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition. Proc. Natl. Acad. Sci. USA 106(44), 18792-18797 (2009).
44. Wells RM, Jones CM, Xi Z et al. Discovery of a siderophore export system essential for virulence of Mycobacterium tuberculosis. PLoS Pathog. 9(1), e1003120 (2013).
45. Adilakshmi T, Ayling PD, Ratledge C. Mutational analysis of a role for salicylic acid in iron metabolism of Mycobacterium smegmatis. J. Bacteriol. 182(2), 264-271 (2000).
46. Tullius MV, Harth G, Maslesa-Galic S, Dillon BJ, Horwitz MA. A replication-limited recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG. Infect. Immune. 76(11), 5200-5214 (2008).
47. Raghu B, Sarma CR, Venkatesan P. Effect of hemoglobin on the growth of mycobacteria and the production of siderophores. Indian J. Pathol. Microbiol. 36(4), 376-382 (1993).
48. Stojiljkovic I, Kumar V, Srinivasan N. Non-iron metalloporphyrins: potent antibacterial compounds that exploit haem/Hb uptake systems of pathogenic bacteria. Mol. Microbiol. 31(2), 429-442 (1999).
49. Jones CM, Niederweis M. Mycobacterium tuberculosis can utilize heme as an iron source. J. Bacteriol. 193(7), 1767-1770 (2011).
50. Czjzek M, Arnoux P, Haser R et al. The crystal structure of HasA, a hemophore secreted by Serratia marcescens. Nat. Struct. Mol. Biol. 6(6), 516-520 (1999).
51. Owens CP, Du J, Dawson JH, Goulding CW. Characterization of heme ligation properties of Rv0203, a secreted heme binding protein involved in Mycobacterium tuberculosis heme uptake. Biochemistry 51(7), 1518-1531 (2012).
52. Domenech P, Reed MB, Barry CE. Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect. Immun. 73(6), 3492-3501 (2005).
53. Lamichhane G, Tyagi S, Bishai WR. Designer arrays for defined mutant analysis to detect genes essential for survival of Mycobacterium tuberculosis in mouse lungs. Infect. Immun. 73(4), 2533-2540 (2005).
54. Paulsen IT, Brown MH, Skurray RA. Proton-dependent multidrug efflux systems. Microbiol. Mol. Biol. Rev. 60(4), 575-608.
55. Milano A, Pasca MR, Provvedi R et al. Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system. Tuberculosis (Edinb.). 89(1), 84-90 (2009).
56. Rodrigues L, Machado D, Couto I, Amaral L, Viveiros M. Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex. Infect. Genet. Evol. 12(4), 695-700 (2012).
57. Converse SE, Mougous JD, Leavell MD, Leary JA, Bertozzi CR, Cox JS. MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence. Proc. Natl. Acad. Sci. USA 100(10), 6121-6126 (2003).
58. Seeliger JC, Holsclaw CM, Schelle MW et al. Elucidation and chemical modulation of sulfolipid-1 biosynthesis in Mycobacterium tuberculosis. J. Biol. Chem. 287(11), 7990-8000 (2012).
59. Tahlan K, Wilson R, Kastrinsky DB et al. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 56(4), 1797-1809 (2012).
60. Grzegorzewicz AE, Pham H, Gundi VAKB et al. Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane. Nat. Chem. Biol. 8(4), 334-341 (2012).
61. Varela C, Rittmann D, Singh A et al. MmpL genes are associated with mycolic acid metabolism in mycobacteria and corynebacteria. Chem. Biol. 19(4), 498-506 (2012).
62. Owens CP, Chim N, Graves, AB et al. The Mycobacterium tuberculosis secreted protein, Rv0203, transfers heme to membrane proteins, Mycobacterial membrane protein Large 3 (MmpL3) and MmpL11. J. Biol. Chem. doi:10.1074/jbc. M113.453076 (2013) (Epub ahead of print).
63. Chim N, Iniguez A, Nguyen TQ, Goulding CW. Unusual diheme conformation of the heme-degrading protein from Mycobacterium tuberculosis. J. Mol. Biol. 395(3), 595-608 (2010).
64. Nambu S, Matsui T, Goulding CW, Takahashi S, Ikeda-Saito M. A new way to degrade heme: the Mycobacterium tuberculosis enzyme MhuD catalyzes heme degradation without generating CO. J. Biol. Chem. (2013).
65. Aranda R IV, Worley CE, Liu M, Bitto E. Bis-methionyl coordination in the crystal structure of the heme-binding domain of the streptococcal cell surface protein Shp. J. Mol. Biol. 374(2), 374-283 (2007).
66. Grigg JC, Vermeiren CL, Heinrichs DE, Murphy MEP. Heme coordination by Staphylococcus aureus IsdE. J. Biol. Chem. 282(39), 28815-28822 (2007).
67. Izadi-Pruneyre N, Huché F, Lukat-Rodgers GS et al. The heme transfer from the soluble HasA hemophore to its membrane-bound receptor HasR is driven by protein-protein interaction from a high to a lower affinity binding site. J. Biol. Chem. 281(35), 25541-25550 (2006).
68. Hu J, Miller MJ. Total synthesis of a mycobactin S, a siderophore and growth promoter of Mycobacterium smegmatis, and determination of its growth inhibitory activity against Mycobacterium tuberculosis. J. Am. Chem. Soc. 119(15), 3462-3468 (1997).
69. Banerjee S, Farhana A, Ehtesham NZ, Hasnain SE. Iron acquisition, assimilation and regulation in mycobacteria. Infect. Genet. Evol. 11(5), 825-838 (2011).
70. Plaha DS, Rogers HJ. Antibacterial effect of the scandium complex of enterochelin. Studies of the mechanism of action. Biochim. Biophys. Acta. 760(2), 246-255 (1983).
71. Stojiljkovic I, Evavold BD, Kumar V. Antimicrobial properties of porphyrins. Expert Opin. Investig. Drugs. 10(2), 309-320 (2001).
72. Cupello MP, Souza CF, Buchensky C et al. The heme uptake process in Trypanosoma cruzi epimastigotes is inhibited by heme analogues and by inhibitors of ABC transporters. Acta Trop. 120(3), 211-218 (2011).
73. Tiedemann MT, Pinter TBJ, Stillman MJ. Insight into blocking heme transfer by exploiting molecular interactions in the core Isd heme transporters IsdA-NEAT, IsdC-NEAT, and IsdE of Staphylococcus aureus. Metallomics 4(8), 751-760 (2012).
74. Ji C, Juárez-Hernández RE, Miller MJ. Exploiting bacterial iron acquisition: siderophore conjugates. Future Med. Chem. 4(3), 297-313 (2012).
75. Miller MJ, Walz AJ, Zhu H et al. Design, synthesis, and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malaria. J. Am. Chem. Soc. 133(7), 2076-2079 (2011).
76. Zhu YY, Silverman RBR. Electronic effects of peripheral substituents at porphyrin meso positions. J. Org. Chem. 72(1), 233-239 (2007).
77. Ekworomadu MT, Poor CB, Owens CP et al. Differential function of lip residues in the mechanism and biology of an anthrax hemophore. PLoS Pathog. 8(3), e1002559 (2012).
78. Sosnik A, Carcaboso AM, Glisoni RJ, Moretton MA, Chiappetta DA. New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery. Adv. Drug Deliv. Rev. 62(4-5), 547-559 (2010).
79. Nikonenko BV, Reddy VM, Protopopova M, Bogatcheva E, Einck L, Nacy CA. Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis. Antimicrob. Agents Chemother. 53(7), 3138-3139 (2009).
80. Iyer AK, Greish K, Fang J, Murakami R, Maeda H. High-loading nanosized micelles of copoly(styrene-maleic acid)-zinc protoporphyrin for targeted delivery of a potent heme oxygenase inhibitor. Biomaterials 28(10), 1871-1881 (2007).
81. Nakamura H, Fang J, Gahininath B, Tsukigawa K, Maeda H. Intracellular uptake and behavior of two types zinc protoporphyrin (ZnPP) micelles, SMA-ZnPP and PEG-ZnPP as anticancer agents; unique intracellular disintegration of SMA micelles. J. Control. Release 155(3), 367-375 (2011).
82. Fang J, Greish K, Qin H et al. HSP32 (HO-1) inhibitor, copoly(styrene-maleic acid)-zinc protoporphyrin IX, a water-soluble micelle as anticancer agent: in vitro and in vivo anticancer effect. Eur. J. Pharm. Biopharm. 81(3), 540-547 (2012).
83. Barker KD, Barkovits K, Wilks A. Metabolic flux of extracellular heme uptake in Pseudomonas aeruginosa is driven by the iron-regulated heme oxygenase (HemO). J. Biol. Chem. 287(22), 18342-18350 (2012).
84. Deidda D, Lampis G, Fioravanti R et al. Bactericidal activities of the pyrrole derivative BM212 against multidrug-resistant and intramacrophagic Mycobacterium tuberculosis strains. Antimicrob. Agents Chemother. 42(11), 3035-3037 (1998).
85. La Rosa V, Poce G, Canseco JO et al. MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212. Antimicrob. Agents Chemother. 56(1), 324-331 (2012).
86. Brown JR, North EJ, Hurdle JG et al. The structure-activity relationship of urea derivatives as anti-tuberculosis agents. Bioorg. Med. Chem. 19(18), 5585-5595 (2011).
87. Scherman MS, North EJ, Jones V et al. Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability. Bioorg. Med. Chem. 20(10), 3255-3262 (2012).
88. Stanley SA, Grant SS, Kawate T et al. Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening. ACS Chem. Biol. 7(8), 1377-1384 (2012).
89. Protopopova M, Hanrahan C, Nikonenko B et al. Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines. J. Antimicrob. Chemother. 56(5), 968-974 (2005).
90. Reddy VM, Einck L, Andries K, Nacy CA. In vitro interactions between new antitubercular drug candidates SQ109 and TMC207. Antimicrob. Agents Chemother. 54(7), 2840-2846 (2010).
91. Reddy VM, Dubuisson T, Einck L et al. SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro. J. Antimicrob. Chemother. 67(5), 1163-1166 (2012).
92. Jia L, Noker PE, Coward L, Gorman GS, Protopopova M, Tomaszewski JE. Interspecies pharmacokinetics and in vitro metabolism of SQ109. Br. J. Pharmacol. 147(5), 476-485 (2006).
93. Hopkinson BM, Roe KL, Barbeau KA. Heme uptake by Microscilla marina and evidence for heme uptake systems in the genomes of diverse marine bacteria. Appl. Environ. Microbiol. 74(20), 6263-6270 (2008).
94. Grigg JC, Cheung J, Heinrichs DE, Murphy MEP. Specificity of staphyloferrin B recognition by the SirA receptor from Staphylococcus aureus. J. Biol. Chem. 285(45), 34579-34588 (2010).
95. Lei B, Liu M, Voyich JM et al. Identification and characterization of HtsA, a second heme-binding protein made by Streptococcus pyogenes. Infect. Immun. 71(10), 5962-5969 (2003).
96. Hagan EC, Mobley H. Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol. Microbiol. 71(1), 79-91 (2009).
97. Frederick RER, Mayfield JAJ, DuBois JLJ. Iron trafficking as an antimicrobial target. Biometals 22(4), 583-593 (2009).
98. World Health Organization. Tuberculosis Global Facts. www.who.int/entity/tb/publications/2011/factsheet-tb-2011.pdf